This application note describes the optimization of MOI and evaluation of commonly used multiwell microplates for the development of transient cell based assays using Ad-A-Gene EGFP-MAPKAP kinase 2 and Ad-A-Gene EGFP-SMAD9.
 | |||||||||||||
|
|
|||||||||||||
|
|||||||||||||
|
|||||||||||||
Location: Home > LitDocs > Application Note > Optimization of assay parameters for Ad-A-Gene EGFP-MAPKAP kinase 2 and Ad-A-Gene EGFP-SMAD9 Assays
| Optimization of assay parameters for Ad-A-Gene EGFP-MAPKAP kinase 2 and Ad-A-Gene EGFP-SMAD9 Assays
|
Products & Solutions | Contact Us | Terms and Conditions | Privacy Policy | Feedback | Site Map
GE Healthcare Home | About GE Healthcare | Our Commitment | GE Corporate Home | Our Company | Financial Services
© 2010 General Electric Company, doing business as GE Healthcare
